The Rapid-Start Program provides pharmaceutical developers with a quick and cost-effective solution for determining the feasibility of using Activ-Blister™ solutions to solve their oral solid dose drug stability challenges.

Why Rapid-Start Program?

  • Accelerates time-to-market and de-risks drug product development
  • Enables a low cost solution to determine feasibility of your drug product using Activ-Blister™ solutions
  • Fast sample production with Activ-Blister™ samples delivered in as little as 4 weeks
  • Streamlined specifications simplify the process of selecting the right solution for your drug product

Watch Our Video on Activ-Blister™ Solutions